Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Open this folder and view contentsIII. Second workshop
Close this folderIV. Preliminary findings
Close this folder1. The methods: What has been learnt?
View the document1.1 Methods in context: How did the country teams use the methods?
View the document1.2 Methods in question: What were the main problems encountered and how to solve them?
View the document1.3 Relevance of the methods
Open this folder and view contents2. National drug policies: what has been learnt?
Open this folder and view contents3. Cross national analysis: What can be learnt at this stage?
View the document4. Broader capacity building
Open this folder and view contentsV. Conclusions of the workshop and follow-up plans
Open this folder and view contentsAnnex 1: Research proposal
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Open this folder and view contentsAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series

1. The methods: What has been learnt?

Three main issues were discussed during the workshop in relation to the methods: their use by the country teams (see 1.1), the methodological problems faced by countries in applying them (see 1.2) and the relevance of the methods to achieve the objectives of the research (see 1.3).

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017